Literature DB >> 3614096

Complement dependent in vitro neutralization of Chlamydia trachomatis by a subspecies-specific monoclonal antibody.

D P Fedorko, R B Clark, I Nachamkin, H P Dalton.   

Abstract

Three murine monoclonal antibodies which combined specifically with Chlamydia trachomatis strain HAR-13 (Serotype A) were characterized. All antibodies cross-reacted with subspecies-specific epitopes in previously undescribed patterns. One of the antibodies showed a complement-dependent partial neutralization of strain HAR-13 in vitro, whereas the remaining two antibodies did not neutralize under any experimental conditions tested. The significance of subspecies-specific antibodies in neutralizing chlamydial infectivity in vivo remains to be determined.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3614096     DOI： 10.1007/bf00196690

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  9 in total

1.  Neutralization of Chlamydia trachomatis in cell culture.

Authors:  L V Howard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 2.  New knowledge of chlamydiae and the diseases they cause.

Authors:  J T Grayston; S Wang
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

3.  Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies.

Authors:  M E Lucero; C C Kuo
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.

Authors:  H D Caldwell; P J Hitchcock
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Localization of distinct surface antigens on Chlamydia trachomatis HAR-13 by immune electron microscopy with monoclonal antibodies.

Authors:  R B Clark; I Nachamkin; P F Schatzki; H P Dalton
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein.

Authors:  H D Caldwell; L J Perry
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

8.  In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.

Authors:  R Peeling; I W Maclean; R C Brunham
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Recovery of Chlamydia trachomatis from patients of southeastern venereal disease clinic.

Authors:  B S Bradley; L M Fisher; H P Dalton
Journal:  Am J Clin Pathol       Date:  1980-06       Impact factor: 2.493
  9 in total
  2 in total

1.  Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).

Authors:  I S Barsoum; T A Goodman; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

Review 2.  A comprehensive review on avian chlamydiosis: a neglected zoonotic disease.

Authors:  Karthikeyan Ravichandran; Subbaiyan Anbazhagan; Kumaragurubaran Karthik; Madesh Angappan; Balusamy Dhayananth
Journal:  Trop Anim Health Prod       Date:  2021-07-27       Impact factor: 1.559
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.